Company: ATLN
Filing Date: 2025-07-08
Form Type: 424B3
Source: 0001213900-25-062079
Chunk: 6

Company: ATLANTIC INTERNATIONAL CORP.
Filing Date: 2025-07-08
Form: 424B3
Chunk 6
---
 otherwise noted, the terms “the Company,” “Atlantic,” “we,” “us,” and “our” refer to Atlantic International Corp.

<div align='center'>Overview</div>

Atlantic International Corp.
(“Atlantic”) (Nasdaq: ATLN) is a leading strategic staffing, outsourced services, and workforce solutions company executing
a high-growth strategy. Through its principal operating subsidiary, Lyneer Investments LLC (“Lyneer”), Atlantic provides its
customers with complete HR solutions, operating 40 independent on-site and vendor-on-premises facilities and paying over 12,000 employees
weekly. According to Staffing Industry Analysts, Atlantic is among the top 20 largest national staffing companies servicing the light
industrial, commercial, professional, finance, direct placement, and managed service provider verticals. Atlantic’s approximately
300 employees generated over $442 million in revenue for the year ended December 31, 2024.

<div align='center'>Corporate Information</div>

We were incorporated in Delaware
under the name SeqLL Inc. on April 1, 2014. We historically operated as a commercial-stage life science instrumentation and research
services company engaged in development of scientific assets and novel intellectual property across multiple “Omics” fields.
Pursuant to the terms and Conditions of the Amended and Restated Agreement and Plan of Reorganization dated as of June 4, 2024, as amended
(the “Merger Agreement”), all of our current business operation have been sold to SeqLL Omics, a newly formed company owned
by our former employees and management, our business is now that of Lyneer. Our corporate headquarters have been relocated to 270 Sylvan
Avenue, Suite 2230, Englewood Cliffs, New Jersey 07632. Our main telephone number at that address is (201) 899-4470, and our website
address is www.atlantic-international.com. The information on our website is not part of this prospectus. We have included our
website address as a factual reference and do not intend it to be an active link to our website.

On August 30, 2023, we amended
our amended and restated certificate of incorporation to effect a one-for-40 reverse stock split of our common stock and to increase our
authorized shares of common stock from 80,000,000 shares to 300,000,000 shares.

On June 13, 2024, in preparation
for the